ITCI logo

Intra-Cellular Therapies (ITCI) Net Margin

Annual Net Margin

-10.97%
+19.25%+63.70%

December 31, 2024


Summary


Performance

ITCI Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITCIprofitabilitymetrics:

Quarterly Net Margin

-8.48%
+6.55%+43.58%

December 1, 2024


Summary


Performance

ITCI Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITCIprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

ITCI Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+63.7%0.0%
3 y3 years+96.8%+56.0%
5 y5 years-+56.0%

ITCI Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+96.8%at high+97.5%
5 y5-yearat high+98.9%at high+99.8%
alltimeall timeat high+100.0%at high+100.0%

Intra-Cellular Therapies Net Margin History

DateAnnualQuarterly
Dec 2024
-10.97%(-63.7%)
-
Dec 2024
-
-8.48%(-43.6%)
Sep 2024
-
-15.03%(+49.4%)
Jun 2024
-
-10.06%(-4.5%)
Mar 2024
-
-10.53%(-51.5%)
Dec 2023
-30.22%(-70.6%)
-21.73%(+12.7%)
Sep 2023
-
-19.28%(-50.4%)
Jun 2023
-
-38.85%(-16.5%)
Mar 2023
-
-46.50%(-7.6%)
Dec 2022
-102.86%(-70.4%)
-50.35%(-32.4%)
Sep 2022
-
-74.45%(-52.7%)
Jun 2022
-
-157.25%(-24.2%)
Mar 2022
-
-207.51%(-38.2%)
Dec 2021
-347.73%(-65.5%)
-336.00%(-5.6%)
Sep 2021
-
-355.96%(-1.6%)
Jun 2021
-
-361.68%(+6.8%)
Mar 2021
-
-338.53%(-30.8%)
Dec 2020
-1007.53%
-489.35%(-34.7%)
Sep 2020
-
-748.90%(-78.0%)
DateAnnualQuarterly
Jun 2020
-
-3396.38%(-36.8%)
Mar 2020
-
-5372.21%(-99.1%)
Dec 2017
-39.77 K%(+13.0%)
-597.60 K%(+703.6%)
Sep 2017
-
-74.37 K%(+380.4%)
Jun 2017
-
-15.48 K%(-45.2%)
Mar 2017
-
-28.27 K%(+0.7%)
Dec 2016
-35.21 K%(-89.7%)
-28.08 K%(-96.0%)
Sep 2016
-
-693.84 K%(+5040.5%)
Jun 2016
-
-13.50 K%(-64.0%)
Dec 2015
-341.80 K%(+5997.9%)
-
Jun 2015
-
-37.48 K%(-94.4%)
Mar 2015
-
-672.30 K%(+1497.1%)
Dec 2014
-5605.28%(+471.0%)
-42.09 K%(+716.3%)
Sep 2014
-
-5156.58%(+149.4%)
Jun 2014
-
-2067.86%(-23.6%)
Mar 2014
-
-2707.77%(+178.7%)
Dec 2013
-981.67%(+84.5%)
-971.66%(+32.1%)
Sep 2013
-
-735.32%
Dec 2012
-532.10%
-

FAQ

  • What is Intra-Cellular Therapies annual net profit margin?
  • What is the all time high annual net margin for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies annual net margin year-on-year change?
  • What is Intra-Cellular Therapies quarterly net profit margin?
  • What is the all time high quarterly net margin for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies quarterly net margin year-on-year change?

What is Intra-Cellular Therapies annual net profit margin?

The current annual net margin of ITCI is -10.97%

What is the all time high annual net margin for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high annual net profit margin is -10.97%

What is Intra-Cellular Therapies annual net margin year-on-year change?

Over the past year, ITCI annual net profit margin has changed by +19.25% (+63.70%)

What is Intra-Cellular Therapies quarterly net profit margin?

The current quarterly net margin of ITCI is -8.48%

What is the all time high quarterly net margin for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high quarterly net profit margin is -8.48%

What is Intra-Cellular Therapies quarterly net margin year-on-year change?

Over the past year, ITCI quarterly net profit margin has changed by 0.00% (0.00%)